XML 49 R37.htm IDEA: XBRL DOCUMENT v3.22.4
Goodwill and Other Intangible Assets, Net (Tables)
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill by Operating Segment
Goodwill
In the first quarter of 2021, in connection to the Merger, the Company reorganized its reporting structure. In connection with this reorganization, goodwill was reassigned among reporting units using a relative fair value approach based on the fair value of the elements transferred and the fair value of the elements remaining within the original reporting units. The Company tested goodwill for impairment on a pre-reorganization basis and determined there was no impairment for the affected reporting units. In connection with the reorganization, $985 million of goodwill previously included in the legacy Taste segment, now the Nourish segment, was moved to the Scent and Health & Biosciences segments amounting to $257 million and $728 million, respectively.
Movements in goodwill attributable to each reportable segment during the years ended December 31, 2021 and 2022 were as follows:
(DOLLARS IN MILLIONS)NourishHealth & BiosciencesScentPharma SolutionsTotal
Balance at December 31, 2020$4,859 $— $734 $— $5,593 
Acquisitions(1)
2,900 6,712 876 1,329 11,817 
Transferred to assets held for sale(2)
— (536)— — (536)
Reduction from business divestiture(27)— — — (27)
Foreign exchange(192)(155)(39)(47)(433)
Reallocation(985)728 257 — — 
Balance at December 31, 20216,555 6,749 1,828 1,282 16,414 
Acquisitions(3)
— 45 — — 45 
Impairment— (2,250)— — (2,250)
Transferred to assets held for sale(4)
(306)— (42)— (348)
Foreign exchange(199)(223)(41)(43)(506)
Balance at December 31, 2022$6,050 $4,321 $1,745 $1,239 $13,355 
_______________________ 
(1)Acquisitions relate to the Merger with N&B. See Note 3 for additional information.
(2)Transferred to assets held for sale relate to the Microbial Control business unit that was classified as “held for sale” as of December 31, 2021.
(3)Acquisitions relate to the acquisition of Health Wright. See Note 3 for additional information.
(4)Transferred to assets held for sale relate to the portion of the Savory Solutions business and Flavor Specialty Ingredients business that were classified as “held for sale” as of December 31, 2022. See Note 21 for additional information.
Schedule of Other Intangible Assets
Other intangible assets, net consisted of the following amounts:
 December 31,
(DOLLARS IN MILLIONS)20222021
Asset Type
Customer relationships$8,318 $8,935 
Technological know-how2,339 2,494 
Trade names & patents358 411 
Other47 50 
Total carrying value 11,062 11,890 
Accumulated Amortization
Customer relationships(1,252)(887)
Technological know-how(589)(388)
Trade names & patents(97)(68)
Other(42)(41)
Total accumulated amortization(1,980)(1,384)
Other intangible assets, net$9,082 $10,506 
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Amortization expense for the next five years and thereafter, based on valuations and determinations of useful lives, is expected to be as follows:
December 31,
(DOLLARS IN MILLIONS)20232024202520262027
Estimated future intangible amortization expense$703 $702 $699 $697 $598